Deflazacort Oral Suspension 22.75 mg/mL
Deflazacort · SUSPENSION · Zydus Pharmaceuticals (USA) Inc.
Deflazacort is a prescription corticosteroid suspension used to reduce inflammation and suppress immune system activity in various conditions. It is taken by mouth and comes in a liquid form at a concentration of 22.75 mg/mL.
Key Facts
- Brand Name
- Deflazacort Oral Suspension
- Generic Name
- Deflazacort
- NDC Code (Product)
70710-2007- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Strength
- 22.75 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA220042
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 10/23/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Deflazacort Oral Suspension used for?
Deflazacort is a prescription corticosteroid suspension used to reduce inflammation and suppress immune system activity in various conditions. It is taken by mouth and comes in a liquid form at a concentration of 22.75 mg/mL.
Is Deflazacort Oral Suspension a controlled substance?
Deflazacort Oral Suspension is not classified as a controlled substance by the DEA.
What is the generic name for Deflazacort Oral Suspension?
The generic name for Deflazacort Oral Suspension is Deflazacort. There are 12 other brand versions of Deflazacort.
What is the NDC code for Deflazacort Oral Suspension 22.75 mg/mL?
The NDC (National Drug Code) for Deflazacort Oral Suspension 22.75 mg/mL is 70710-2007, listed by Zydus Pharmaceuticals (USA) Inc..